Edico Genome was one of the companies discussed. This week, it's been acquired by Illumina for $100M. Over the past several years, Edico had raised $32M in venture capital.
Edico enables both research and clinical technologies; for example, it's been used by Rady Children's Hospital in landmark applications of rapid genomic sequencing in very ill babies. (See Farnaes et al., 2018, here.)
Illumina has a market cap of $38B and cash and equivalents of $2B.